Healthcare - Biotechnology - NASDAQ - US
$ 0.037
0 %
$ 453 K
Market Cap
-0.04
P/E
CASH FLOW STATEMENT
-17.8 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
-40 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Bellerophon Therapeutics, Inc.
| Net Income | -19.8 M |
| Depreciation & Amortization | 65 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 786 K |
| Change in Working Capital | 1.21 M |
| Others | 385 K |
| Free Cash Flow | -17.8 M |
Cash Flow
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (19.8) | (17.8) | (24.7) | (13.3) | 2.8 | (54.8) | (23.8) | (46.5) | (59.7) | (62.0) | (46.2) |
| Depreciation & Amortization | 65 K | 0.1 | 0.1 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 85 K |
| Deferred Income Tax | 0 | 0 | 0.3 | 0 | (2.8) | 6 K | 34 K | 0 | 0 | 0 | 2.8 |
| Stock Based Compensation | 0.8 | 1.1 | 1.6 | 2.2 | 3.0 | 2.8 | 2.8 | 1.8 | 1.8 | 1.7 | 1.4 |
| Other Operating Activities | 1 K | (0.6) | 0.3 | (2.0) | (22.1) | 30.5 | 1.0 | 45 K | 0 | 0.1 | 0.3 |
| Change in Working Capital | 1.2 | (5.7) | 2.4 | (0.2) | 3.3 | 5.4 | 2.4 | (2.0) | (13.1) | 2.5 | 5.3 |
| Cash From Operations | (17.8) | (22.8) | (19.9) | (12.9) | (15.5) | (15.7) | (17.2) | (46.3) | (70.6) | (57.2) | (36.2) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 22 K | (0.5) | 0 | (0.7) | (3.5) |
| Other Items | 0 | 0 | 0 | 0 | 3.0 | 2.6 | 12.2 | (17.8) | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 3.0 | 2.6 | 12.2 | (18.3) | 0 | (0.7) | (3.5) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 28 K | 0 | 0 | 0 | 29 K | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 40 K | 0 | 2.9 | 69 K | 0.2 | 2.5 | (0.1) | 0.2 | 87.4 | 58.0 | 39.7 |
| Cash From Financing Activities | 40 K | 0 | 57.6 | 6.2 | 0.2 | 27.8 | 13.2 | 54.0 | 87.4 | 58.0 | 39.7 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (17.8) | (22.8) | 37.7 | (6.8) | (12.3) | 14.6 | 8.2 | (10.6) | 16.8 | 0 | 0 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (17.8) | (22.8) | (19.9) | (12.9) | (15.5) | (15.7) | (17.2) | (46.7) | (70.6) | (58.0) | (39.7) |